78 FIRST-LINE MODIFIED SCHEDULE OF GEMCITABINE INDUCES HIGH CLINICAL BENEFIT RATE WITHOUT SIGNIFICANT TOXICITY IN ELDERLY OR NOT ELDERLY ECOG PS 2 PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
Titel:
78 FIRST-LINE MODIFIED SCHEDULE OF GEMCITABINE INDUCES HIGH CLINICAL BENEFIT RATE WITHOUT SIGNIFICANT TOXICITY IN ELDERLY OR NOT ELDERLY ECOG PS 2 PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
Auteur:
Nacci, A. Mazzoni, E. Rizzo, P. Orlando, L. Sponziello, F. Calvani, N. Schiavone, P. D'Amico, M. Marino, A. Fedele, P. Chetri, M.C. Cinefra, M. Cinieri, S.